[1]
Pittayawonganon, C., Pisitpayat, N., Kripattanapong, S., Doungngern, P. and Jitpeera, C. 2024. Effectiveness and Safety of Long-acting Antibody (LAAB) to Prevent COVID-19 among High-risk Population in Thailand: a 6-month Retro-prospective Cohort Study. Outbreak, Surveillance, Investigation & Response (OSIR) Journal. 17, 3 (Sep. 2024), 155–164. DOI:https://doi.org/10.59096/osir.v17i3.270829.